Long-term β-Blocker vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy: A double-blind, randomized study of bucindolol versus placebo
- 31 March 1990
- journal article
- clinical trial
- Published by Elsevier BV in American Journal Of Medicine
- Vol. 88 (3), 223-229
- https://doi.org/10.1016/0002-9343(90)90146-5
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Increased beta-receptor density and improved hemodynamic response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy.Circulation, 1989
- Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomized, placebo-controlled trial.Circulation, 1985
- A randomized trial of low-dose beta-blockade therapy for idiopathic dilated cardiomyopathyThe American Journal of Cardiology, 1985
- Beta blockade for dilated cardiomyopathy: the evidence against therapeutic benefitEuropean Heart Journal, 1983
- Beta-blockers in dilated cardiomyopathies: they workEuropean Heart Journal, 1983
- DOUBLE-BLIND TRIAL OF CHRONIC ORAL BETA BLOCKADE IN CONGESTIVE CARDIOMYOPATHYThe Lancet, 1981
- Adverse effects of beta-blockade withdrawal in patients with congestive cardiomyopathy.Heart, 1980
- Haemodynamic effects of acute beta-adrenergic receptor blockade in congestive cardiomyopathy.Heart, 1979
- PROLONGATION OF SURVIVAL IN CONGESTIVE CARDIOMYOPATHY BY BETA-RECEPTOR BLOCKADEThe Lancet, 1979
- Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy.Heart, 1975